Application of Quantitative Structure-Activity Relationships in the Prediction of New Compounds with Anti-Leukemic Activity
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241512258 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Cristian Sandoval und 4 weiteren Autor:innen. Beteiligte Einrichtung: Escuela de Tecnología Médica, Facultad de Salud, Universidad Santo Tomás, Los Carreras 753, Osorno 5310431, Chile. Hauptthemen laut MEDLINE: Neoplasms, Leukemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of La Frontera, Universidad de La Frontera, FAPESP-UFRO.
Abstract (Originalsprache)
Leukemia invades the bone marrow progressively and, through unknown mechanisms, outcompetes healthy hematopoiesis. Protein arginine methyltransferases 1 (PRMT1) are found in prokaryotes and eukaryotes cells. They are necessary for a number of biological processes and have been linked to several human diseases, including cancer. Small compounds that target PRMT1 have a significant impact on both functional research and clinical disease treatment. In fact, numerous PRMT1 inhibitors targeting the S-adenosyl-L-methionine binding region have been studied. Through topographical descriptors, quantitative structure-activity relationships (QSAR) were developed in order to identify the most effective PRMT1 inhibitors among 17 compounds. The model built using linear discriminant analysis allows us to accurately classify over 90% of the investigated active substances. Antileukemic activity is predicted using a multilinear regression analysis, and it can account for more than 56% of the variation. Both analyses are validated using an internal “leave some out” test. The developed model could be utilized in future preclinical experiments with novel drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Escuela de Tecnología Médica, Facultad de Salud, Universidad Santo Tomás, Los Carreras 753, Osorno 5310431, Chile.
- Departamento de Ingeniería Química, Facultad de Ingeniería y Ciencias, Universidad de La Frontera, Temuco 4811230, Chile.
- Departamento de Ciencias Preclínicas, Facultad de Medicina, Universidad de La Frontera, Temuco 4811230, Chile.
- Institut Universitari de Ciència Molecular, Universitat de València, 46071 València, Spain.
- Nucleo Científico y Tecnológico en Biorecursos (BIOREN), Universidad de La Frontera, Temuco 4811230, Chile.
- Carrera de Tecnología Médica, Facultad de Medicina, Universidad de La Frontera, Temuco 4811230, Chile.
ORCID-Profile: Cristian Sandoval, Francisco Torrens, Jorge Farías
Förderung
- University of La Frontera
- Universidad de La Frontera
- FAPESP-UFRO
Zitieren
APA
Sandoval, C., Torrens, F., Godoy, K., Reyes, C., & Farías, J. (2023). Application of Quantitative Structure-Activity Relationships in the Prediction of New Compounds with Anti-Leukemic Activity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241512258
Vancouver
Sandoval C, Torrens F, Godoy K, Reyes C, Farías J. Application of Quantitative Structure-Activity Relationships in the Prediction of New Compounds with Anti-Leukemic Activity. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241512258
BibTeX
@article{Sandoval2023,
author = {Sandoval, Cristian and Torrens, Francisco and Godoy, Karina and Reyes, Camila and Farías, Jorge},
title = {Application of Quantitative Structure-Activity Relationships in the Prediction of New Compounds with Anti-Leukemic Activity},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241512258}
}
EUVIMED